Cargando…

Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions

Hepatocellular carcinoma (HCC) is one of most common cancers that cause death in the world. Thermal ablation (TA) is an important alternative treatment method for HCC patients who are not appropriate for surgery or liver transplantation. Particularly for small and early HCCs, TA can be considered as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bo, Xiao-Wan, Sun, Li-Ping, Yu, Song-Yuan, Xu, Hui-Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529921/ https://www.ncbi.nlm.nih.gov/pubmed/34721773 http://dx.doi.org/10.4251/wjgo.v13.i10.1397

Ejemplares similares

Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023)

Recent update on comprehensive therapy for advanced hepatocellular carcinoma
por: Wang, Hui, et al.
Publicado: (2021)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Ablative strategies for recurrent hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2023)

Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
por: Pavel, Mihai-Calin, et al.
Publicado: (2018)

Targets of immunotherapy for hepatocellular carcinoma: An update
por: Rai, Vikrant, et al.
Publicado: (2022)

Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
por: Kang, Tae Wook, et al.
Publicado: (2018)

Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019)

Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
por: Contratto, Merly, et al.
Publicado: (2018)

Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
por: Luo, Yi, et al.
Publicado: (2022)

Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
por: Lu, Ren-Cai, et al.
Publicado: (2019)

Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
por: Cong, Rong, et al.
Publicado: (2023)

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
por: Xu, Weiqi, et al.
Publicado: (2019)

Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions
por: Aslam, Anum, et al.
Publicado: (2020)

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Apatinib as an alternative therapy for advanced hepatocellular carcinoma
por: Zhang, Xi-Hao, et al.
Publicado: (2020)

Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Soil Microbial Biogeography in a Changing World: Recent Advances and Future Perspectives
por: Chu, Haiyan, et al.
Publicado: (2020)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

Immunotherapies in sarcoma: Updates and future perspectives
por: Ghosn, Marwan, et al.
Publicado: (2017)

State-of-the-art management of nasopharyngeal carcinoma: current and future directions
por: Agulnik, M, et al.
Publicado: (2005)

Recent Advancements in and the Future of Organic Emitters: TADF‐ and RTP‐Active Multifunctional Organic Materials
por: Data, Przemyslaw, et al.
Publicado: (2019)

Management of centrally located hepatocellular carcinoma: Update 2016
por: Yu, Wei-Bo, et al.
Publicado: (2017)

Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma
por: Chen, Tian-You, et al.
Publicado: (2023)

Recent progress in pulsed electric field ablation for liver cancer
por: Liu, Zhen-Guo, et al.
Publicado: (2020)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

T-regulatory cell modulation: the future of cancer immunotherapy?
por: Nizar, S, et al.
Publicado: (2009)

Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives
por: Feng, Bing, et al.
Publicado: (2021)

Recent Advances in Immunotherapy for Hepatocellular Carcinoma
por: Nakano, Shigeharu, et al.
Publicado: (2020)

Recent advances in radiotherapy
por: Bhide, SA, et al.
Publicado: (2010)

Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
por: Butt, Amna Subhan, et al.
Publicado: (2018)

Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
por: Lee, Min Woo, et al.
Publicado: (2018)

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
por: Dai, Kai, et al.
Publicado: (2021)

Immunotherapy in Melanoma: Recent Advances and Future Directions
por: Knight, Andrew, et al.
Publicado: (2023)

Immunotherapy in Melanoma: Recent Advancements and Future Directions
por: Mooradian, Meghan J., et al.
Publicado: (2023)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?
por: Chu, Kevin Ka Wan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_df07u6id38t5e5jn9nj08i1s2o